B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028
No. of Pages: 287
B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market
|
01-Jan-2020
|
6250
|
Cutaneous T- Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecast-2028
No. of Pages: 189
Cutaneous T- Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecast-2028’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as
|
01-Jan-2020
|
3250
|
Cystinosis - Market Insights, Epidemiology, and Market Forecast-2028
No. of Pages: 149
Cystinosis - Market Insights, Epidemiology, and Market Forecast-2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market
|
01-Jan-2020
|
6250
|
Fragile X Syndrome (FXS)- Market Insights, Epidemiology, and Market Forecast-2028
No. of Pages: 135
Fragile X Syndrome (FXS)- Market Insights, Epidemiology, and Market Forecast-2028’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as
|
01-Jan-2020
|
6250
|
Generalized Anxiety Disorder (GAD)- Market Insights, Epidemiology, and Market Forecast-2028
No. of Pages: 150
Generalized Anxiety Disorder (GAD)- Market Insights, Epidemiology, and Market Forecast-2028’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as
|
01-Jan-2020
|
6250
|
Heavy Menstrual Bleeding (HMB)- Market Insights, Epidemiology and Market Forecast—2028
No. of Pages: 190
Heavy Menstrual Bleeding (HMB)- Market Insights, Epidemiology and Market Forecast—2028’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as
|
01-Jan-2020
|
6250
|
Hemophilia A—Market Insights, Epidemiology, and Market Forecast—2030
No. of Pages: 239
Hemophilia A—Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends
|
01-Jan-2020
|
6950
|
Hepatocellular carcinoma (HCC)- Market Insights, Epidemiology and Market Forecast-2028
No. of Pages: 233
Hepatocellular carcinoma (HCC)- Market Insights, Epidemiology and Market Forecast-2028 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the
|
01-Jan-2020
|
6250
|
Hot Flashes Associated with Prostate Cancer Treatment - Market Insights, Epidemiology, and Market Forecast-2028
No. of Pages: 154
Hot Flashes Associated with Prostate Cancer Treatment—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as
|
01-Jan-2020
|
6250
|
Postoperative nausea and vomiting (PONV) - Market Insights, Epidemiology, and Market Forecast-2028
No. of Pages: 159
Postoperative nausea and vomiting (PONV) - Market Insights, Epidemiology, and Market Forecast-2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as
|
01-Jan-2020
|
6250
|
Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, and Market Forecast-2028
No. of Pages: 158
Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, and Market Forecast-2028’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as
|
01-Jan-2020
|
6250
|
Sialorrhea- Market Insights, Epidemiology and Market Forecast-2028
No. of Pages: 149
Sialorrhea- Market Insights, Epidemiology and Market Forecast-2028 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market
|
01-Jan-2020
|
6250
|
Acne Vulgaris - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 150
"Acne Vulgaris - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products
|
01-Jan-2020
|
2000
|
Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 60
"Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products for
|
01-Jan-2020
|
2000
|
Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 120
"Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products
|
01-Jan-2020
|
2000
|
Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 120
"Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III
|
01-Jan-2020
|
2000
|
Allergic Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 60
"Allergic Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products
|
01-Jan-2020
|
2000
|
Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 60
"Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products
|
01-Jan-2020
|
2000
|
Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 60
"Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products for
|
01-Jan-2020
|
2000
|
Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
No. of Pages: 60
"Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report by offers comprehensive insights on marketed and Phase III products
|
01-Jan-2020
|
2000
|
